26 Jun, 15:39 - Indian

SENSEX 78674.25 (0.80)

Nifty 50 23868.8 (0.62)

Nifty Bank 52870.5 (0.50)

Nifty IT 35406.55 (-0.06)

Nifty Midcap 100 55245.8 (-0.22)

Nifty Next 50 71235.8 (-0.18)

Nifty Pharma 19545.35 (0.07)

Nifty Smallcap 100 18288 (0.25)

26 Jun, 15:39 - Global

NIKKEI 225 39667.07 (1.26)

HANG SENG 18089.93 (0.09)

DOW JONES 39112.16 (-0.76)

S&P 5469.3 (0.39)

Login/Signup

Hot Pursuit News

You are Here : Home > Markets > News > Hot Pursuit News

(28 Feb 2024, 12:57)

Bajaj Healthcare soars after signing deal for supply of 15 APIs with UK/EU customers

Bajaj Healthcare surged 11.13% to Rs 356.05 after the company announced that it has entered into a definitive CDMO agreement with esteemed UK/EU based customers for the supply of 15 active pharmaceutical ingredients (APIs).

Under this agreement, the company will undertake the development and supply of these molecules, which will be exclusively manufactured for its clientele. These APIs encompass a diverse range of compounds, including off-patent generics and molecules soon to be off-patent.

The CDMO agreement will be executed through its in-house R&D and manufacturing capacities at Savli Vadodara, Gujarat.

Anil Jain, joint managing director, Bajaj Healthcare said: "I am thrilled to share this strategic collaboration which underscores Bajaj Healthcare Ltd.’s commitment to innovation, excellence, and meeting the evolving needs of the pharmaceutical industry.

By harnessing our expertise and state-of-the-art infrastructure, we are poised to enhance the accessibility and affordability of essential m...

More News
More Company News